Organization
Ionis Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Ionis Pharmaceuticals, Inc.
... CARLSBAD, Calif. - Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it has licensed a second orally delivered ...
... Ionis Pharmaceuticals has signed the rights to another antisense drug over to Janssen ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it has licensed a second orally delivered ...
... 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), focused on developing and commercializing drugs to treat patients with ...
... Mass. - Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), focused on developing and commercializing drugs to treat patients with ...
... CARLSBAD, Calif. and STRASBOURG, France - Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and Dynacure announced today that Dynacure has licensed IONIS-DNM2-2.5Rx (Dyn101), ...
... of Williams-Sonoma, Inc. (NYSE:WSM), U.S. Silica Holdings, Inc. (NYSE:SLCA), RH (NYSE:RH), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), Burlington Stores, Inc. (NYSE:BURL), and McCormick & Company, Incorporated (NYSE:MKC) ...
... CARLSBAD, Calif. - Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today reported GAAP operating income of $ 13.9 million and ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and Dynacure announced today that Dynacure has licensed IONIS-DNM2-2.5Rx (Dyn101), ...
... If you want a Stock Review on AMRN, ENDP, IONS, or TEVA then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... ALS space include topline Phase I/II and Phase III trial results for IONIS-SOD1Rx, Masitinib, and Tirasemtiv, as well as a Committee for Medicinal Products for ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today management transitions to be effective January 15, 2018. ...
... 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious ...
... CAMBRIDGE, Mass. & CARLSBAD, Calif. - Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that the end of study results from ENDEAR, the ...
... CARLSBAD, Calif. - Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced new data from ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that the company submitted a new drug application ...
... 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today reported financial results for the third quarter ended September 30, ...
... has emerged victorious from its hereditary TTR amyloidosis (hATTR) data face-off against Ionis. Data presented by the RNAi pioneer suggest its patisiran has the edge ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced new data from ...
... CAMBRIDGE, Mass. - Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc. focused on developing and commercializing drugs to treat patients with serious ...
... CAMBRIDGE, Mass. - Biogen (NASDAQ: BIIB) and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best ...
... 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), today announced positive results of a Phase 1/2a clinical study ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it plans to open an expanded access ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that Ionis and Biogen have been awarded the ...
... Biogen (NASDAQ: BIIB) and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best ...
... 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. focused on developing and commercializing drugs to treat patients with serious ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤